424 related articles for article (PubMed ID: 19428896)
21. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests.
Terregino C; Toffan A; Cilloni F; Monne I; Bertoli E; Castellanos L; Amarin N; Mancin M; Capua I
Avian Pathol; 2010 Jun; 39(3):215-22. PubMed ID: 20544428
[TBL] [Abstract][Full Text] [Related]
23. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
Worrall EE; Sudarisman ; Priadi A
Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
[TBL] [Abstract][Full Text] [Related]
24. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
25. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
26. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
27. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
Beard CW; Schnitzlein WM; Tripathy DN
Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
Rudolf M; Pöppel M; Fröhlich A; Breithaupt A; Teifke J; Blohm U; Mettenleiter T; Beer M; Harder T
Vaccine; 2010 Oct; 28(42):6832-40. PubMed ID: 20727963
[TBL] [Abstract][Full Text] [Related]
29. Highly pathogenic avian influenza (H5N1) in ducks and in-contact chickens in backyard and smallholder commercial duck farms in Viet Nam.
Henning J; Henning KA; Morton JM; Long NT; Ha NT; Vu le T; Vu PP; Hoa DM; Meers J
Prev Vet Med; 2011 Sep; 101(3-4):229-40. PubMed ID: 20594603
[TBL] [Abstract][Full Text] [Related]
30. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
[TBL] [Abstract][Full Text] [Related]
31. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
32. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
[TBL] [Abstract][Full Text] [Related]
33. Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus.
Hwang SD; Kim HS; Cho SW; Seo SH
Vaccine; 2011 Mar; 29(11):2178-86. PubMed ID: 21172378
[TBL] [Abstract][Full Text] [Related]
34. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission.
Ellis TM; Leung CY; Chow MK; Bissett LA; Wong W; Guan Y; Malik Peiris JS
Avian Pathol; 2004 Aug; 33(4):405-12. PubMed ID: 15370037
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.
Garcia A; Johnson H; Srivastava DK; Jayawardene DA; Wehr DR; Webster RG
Avian Dis; 1998; 42(2):248-56. PubMed ID: 9645315
[TBL] [Abstract][Full Text] [Related]
36. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
37. Intraocular vaccination with an inactivated highly pathogenic avian influenza virus induces protective antibody responses in chickens.
Hikono H; Mase M; Matsuu A; Nakayama M; Saito T
Vet Immunol Immunopathol; 2013 Jan; 151(1-2):83-9. PubMed ID: 23159237
[TBL] [Abstract][Full Text] [Related]
38. Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine.
James-Berry CM; Middleton D; Mansfield JP; Fenwick SG; Ellis TM
Vet Rec; 2010 Oct; 167(18):695-9. PubMed ID: 21257485
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus.
Sasaki T; Isoda N; Soda K; Sakamoto R; Saijo K; Hagiwara J; Kokumai N; Ohgitani T; Imamura T; Sawata A; Lin Z; Sakoda Y; Kida H
Jpn J Vet Res; 2009 Feb; 56(4):189-98. PubMed ID: 19358446
[TBL] [Abstract][Full Text] [Related]
40. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
